Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,280
-160 (-1.53%)
Dec 5, 2025, 3:30 PM KST
-7.72%
Market Cap 218.24B
Revenue (ttm) 215.04B
Net Income (ttm) -27.06B
Shares Out 21.23M
EPS (ttm) -1,296.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 223,196
Average Volume 287,829
Open 10,500
Previous Close 10,440
Day's Range 10,160 - 10,800
52-Week Range 9,120 - 15,400
Beta 0.34
RSI 50.84
Earnings Date Nov 14, 2025

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se... [Read more]

Sector Healthcare
Founded 1947
Employees 583
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.